Brii Biosciences Limited
Brii Biosciences Limited (HKSE: 2137) is trading at HK$0.89, about ₹11 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET. Indian residents can buy Brii Biosciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.84
Today's high
HK$0.89
52 week low
HK$0.83
52 week high
HK$2.34
2137 opened at HK$0.88, closed previously at HK$0.89, and has traded between HK$0.83 and HK$2.34 over the past 52 weeks.
About
Founded in Beijing, China, in 2017, Brii Biosciences Limited is a biopharmaceutical firm dedicated to discovering and developing innovative therapies for infectious diseases and central nervous system disorders. Its diverse pipeline features: early-stage (Phase 1) compounds BRII-778 and BRII-732 for treating HIV; a multifaceted approach to Hepatitis B (HBV) including a Phase 2 combination study of BRII-179 and BRII-835, with BRII-179 (a recombinant protein-based immunotherapeutic) also in Phase 1b/2a, and BRII-835 having successfully completed Phase 2 for chronic HBV patients. The company also offers the Amubarvimab/romlusevimab combination as a treatment for COVID-19. Beyond these, Brii Biosciences is advancing BRII-296 for PPD and BRII-297 for various depressive conditions, alongside several agents targeting highly resistant infections: BRII-636, BRII-672, and BRII-693 are designed to combat multi-drug and extensively drug-resistant (MDR/XDR) gram-negative bacteria, while BRII-658 is under development for MDR/XDR tuberculosis and non-tuberculosis mycobacterial infections.
Key statistics
Avg. volume
717.70K
Market cap
HK$641.85M
P/E Ratio
-3.18
Price-to-sales ratio
29.98
Enterprise value
CN¥50.21M
Free cash flow yield
-45.08%
Debt-to-equity ratio
0.00
Return on equity
-7.32%
ROIC
-12.47%
Beta
1.20
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥18.12M
Earnings per share
-CN¥0.30
Free cash flow
-CN¥288.42M
Net profit margin
-918.14%
Gross margin
63.08%
EBITDA
-CN¥290.29M
Revenue growth
-66.61%
Similar securities
This is not an investment recommendation
How to buy Brii Biosciences from India
Indian residents can buy Brii Biosciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Brii Biosciences and place an order
Find Brii Biosciences by name or by its ticker, 2137, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Brii Biosciences trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Brii Biosciences position in HKD and INR. Brii Biosciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Brii Biosciences from India
Trading and taxes when buying Brii Biosciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneBrii Biosciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Brii Biosciences stock?
Yes. Brii Biosciences (2137) has been listed on the Hong Kong Stock Exchange since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Brii Biosciences share cost in rupees?
One Brii Biosciences share is HK$0.89 — about ₹11 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Brii Biosciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Brii Biosciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Brii Biosciences?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Brii Biosciences shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Brii Biosciences price. Paasa issues a capital-gains statement for your return.
Does Brii Biosciences pay a dividend?
No. Brii Biosciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Brii Biosciences from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Brii Biosciences a Hong Kong SAR China company, and does that change how it is taxed?
Brii Biosciences trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Brii Biosciences trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Brii Biosciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Brii Biosciences holding, its cost and its closing value.
How do I sell Brii Biosciences and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.